The $10M convertible note is highly dilutive at a fixed conversion price of $0.6261, representing significant potential dilution relative to the $31M market cap. The onerous terms (200% redemption premium, 12% default interest, extensive negative covenants) signal distressed financing. Monitor for stockholder approval requests and the CVR transaction proxy statement. The notes' senior secured status and redemption provisions create substantial downside risk for common equity holders.
Price Chart
Executive Summary
Senti Biosciences issued $10.0M in aggregate principal amount of Senior Secured Convertible Notes to Celadon Partners SPV 24, creating a new secured debt obligation. The notes carry onerous terms including a 200% redemption premium upon default or change of control, a fixed exchange/conversion price of $0.6261 per share, and extensive negative covenants restricting the company's operations. The filing also discloses a potential transaction involving a contingent value right (CVR) of up to $60.0M tied to SENTI-202 milestones.
Key Financial Metrics
Key Facts
- $10.0M in aggregate principal amount of Senior Secured Convertible Notes issued to Celadon Partners SPV 24
- Notes have a fixed exchange/conversion price of $0.6261 per share
- Maturity date is 6 months from initial closing, extendable by holder upon default or change of control
- 200% redemption premium on outstanding principal upon default, bankruptcy, or change of control
- Interest accrues at 12% per annum only after an Event of Default
- Notes are senior secured, ranking senior to all other indebtedness
- Extensive negative covenants restrict incurring debt, liens, dividends, share repurchases, and affiliate transactions
- Potential CVR transaction of up to $60.0M tied to SENTI-202 regulatory and sales milestones
- Company intends to file proxy statement for stockholder approval of additional note issuances beyond Exchange Cap
- Market cap is ~$31M; the $10M note represents ~32% of market cap
Financial Impact
$10.0M new secured debt, representing ~32% of $31M market cap; potential dilution from conversion at $0.6261/share; up to $60.0M CVR potential
Risk Factors
- Massive potential dilution from note conversion at $0.6261/share relative to current market price
- 200% redemption premium upon default or change of control creates severe cash liability
- Extensive negative covenants severely restrict operational and financial flexibility
- Potential CVR transaction could further complicate capital structure
- Stockholder approval needed for additional note issuances beyond Exchange Cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-038058 |
| Document: snti-20260520.htm | 0001628280-26-038058 |
| Document: 0001628280-26-038058-index-headers.html | 0001628280-26-038058 |
| Document: 0001628280-26-038058-index.html | 0001628280-26-038058 |
| Document: 0001628280-26-038058.txt | 0001628280-26-038058 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 12d ago | DEFA14A | $0.2408 $0.2175 | ▼ −9.68% | ▼ −10.13% | $0.1751 (−27.28%) |
Oct 13, 2026 12d ago | 8-K | $0.2408 $0.2175 | ▲ +9.68% | ▲ +10.13% | $0.1751 (+27.28%) |
Sep 25, 2026 4w ago | EFFECT | $0.3293 $0.3223 | ▲ +2.13% | ▲ +1.90% | $0.1751 (+46.83%) |
Sep 24, 2026 4w ago | DEFM14A | $0.3293 $0.3223 | ▲ +2.13% | ▲ +1.90% | $0.1751 (+46.83%) |
Sep 22, 2026 4w ago | S-3/A | $0.3156 $0.3075 | ▲ +2.57% | ▲ +1.38% | $0.1751 (+44.52%) |
Sep 10, 2026 6w ago | S-3/A | $0.3060 $0.3200 | ▼ −4.58% | ▼ −4.80% | $0.1751 (+42.78%) |
Sep 4, 2026 7w ago | DEFA14A | $0.3326 $0.3021 | ▼ −9.17% | ▼ −7.96% | $0.1751 (−47.35%) |
Sep 4, 2026 7w ago | 8-K | $0.3326 $0.3021 | ▲ +9.17% | ▲ +7.96% | $0.1751 (+47.35%) |
Aug 20, 2026 9w ago | 8-K | $0.3886 $0.3770 | ▲ +2.99% | ▲ +3.46% | $0.1751 (+54.94%) |
Jul 16, 2026 14w ago | S-3/A | $0.4597 $0.4266 | ▲ +7.20% | ▲ +5.53% | $0.1751 (+61.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers